Target intelligence / Profile preview

Wnt signaling pathway activating non-coding RNA (WSPAR)

Target
WSPAR
Molecular classification
Long non-coding RNA (lncRNA), Regulatory RNA, Other
01

Overview

Wnt signaling pathway activating non-coding RNA (WSPAR, also called lncTCF7, among other aliases) is a long non-coding RNA that promotes activation of the canonical Wnt signaling pathway, often by regulating the expression or enhancer activity of TCF7—a major transcription factor in Wnt signaling. WSPAR/lncTCF7 is involved in maintaining stemness features in certain cell types, including cancer cells, and exercises regulatory control over gene expression both at the chromatin and transcriptional level. While not a traditional protein receptor or enzyme, WSPAR is increasingly considered a non-traditional therapeutic target due to its pivotal regulatory role in disease and stem cell biology. The exact molecular mechanism, druggability, and disease roles remain an area of ongoing research. Although WSPAR is best characterized in oncology contexts, its full biological and clinical significance is still being explored.

Other names
TCONS_00009511-XLOC_004555lncTCF7LncTCF7TCONS_00009511
02

Mechanism of action

Regulation of transcriptional complexes in the Wnt pathway; Molecular scaffolding for chromatin modification; Modulation of neighboring and distant gene expression via cis and trans mechanisms

03

Biological functions

Regulation of Wnt signaling pathwayEpigenetic gene regulationTranscriptional regulationCell proliferationDevelopmental programming
04

Disease associations

Cancer (especially stemness in cancer and likely other roles in tumorigenesis)Other (potential roles in differentiation and development)
05

Safety considerations

Targeting lncRNAs may lead to off-target effects due to overlapping regulatory networksLimited tissue specificity and poor conservation across species may complicate therapeutic development
06

Biomarkers

Expression of WSPAR/lncTCF7 (may serve as a biomarker for cancer stemness or prognosis in certain Wnt-driven cancers; clinical validation is limited.)

Beyond the preview

Go deeper on Wnt signaling pathway activating non-coding RNA (WSPAR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wnt signaling pathway activating non-coding RNA (WSPAR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call